Benjamin Parker
A/Prof Benjamin Parker was trained in pharmacology and mass spectrometry in the Australian Sports Drug Testing Laboratory. He completed is PhD at the University of Southern Denmark and University of Sydney where he developed assays to quantify protein modifications by mass spectrometry applied to study cardiovascular disease. He performed post-doctoral research at the Garvan Institute and then obtained an NHMRC Early Career Fellowship in the Metabolic Systems Biology Program at the Charles Perkins Centre. He is currently an NHMRC Emerging Leader Investigator and group leader at The University of Melbourne. He is also President of Proteomics & Metabolomics Victoria, Reviewing Editor at Elife and on the Editorial Board for Nature Metabolic Health and Disease. His research team is focused on understanding how genetic variants and signal transduction regulate metabolism and musculoskeletal health with the goal of identifying new therapeutic targets to treat metabolic disease.
Abstracts this author is presenting: